Oxford Genome Sciences

News

Date	Title

February 18, 2008	Oxford Genome Sciences Appoints Professor Elke Jaeger to its Scientific Advisory Board
December 17, 2007	Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
November 21, 2007	Oxford Genome Sciences Appoints Chris Hibberd to its Board of Directors
October 11, 2007	Sir Walter Bodmer Joins Oxford Genome Sciences Scientific Advisory Board
September 18, 2007	Oxford Genome Sciences Announces New Therapeutic Antibody Deal with Medarex
April 18, 2007	Oxford Genome Sciences Recruits Senior Industry Professionals to Drive its Development of Novel Personalised Medicines
March 5, 2007	Oxford Genome Sciences Expands its Scientific Advisory Board
Feb 5, 2007	Oxford Genome Sciences (UK) Ltd secured additional private equity investment round
May 10, 2006	Oxford Genome Sciences and Medarex Sign Therapeutic Antibody Collaboration Agreement in Cancer
April 12, 2006	Oxford Genome Sciences and University of Oxford to develop new clinical biomarkers for colorectal cancer
April 5, 2006	Biosite and Oxford Genome Sciences Announce Collaboration in Colorectal Cancer
October 18, 2005	Oxford Genome Sciences licences OGAP database to UCB
June 7, 2005	Oxford Genome Sciences appoints Jeff Warren to the Board of Directors
April 4, 2005	Oxford Genome Sciences closes financing and moves to state-of-the-art proteomics facility
March 14, 2005	Bayer HealthCare Diagnostics and Oxford Genome Sciences Partner in Proteomics-based Evaluation of New Biomarkers for Breast Cancer